Litcius/Paper detail

Impact of Bridging Chemotherapy on Clinical Outcomes of CD19-Specific CAR T Cell Therapy in Children/Young Adults with Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia

Sanam Shahid, Kavitha Ramaswamy, Jessica Flynn, Audrey Mauguen, Karlo Perica, Jae H. Park, Christopher J. Forlenza, Neerav Shukla, Peter G. Steinherz, Steven Margossian, Jaap Jan Boelens, Nancy A. Kernan, Kevin J. Curran

2021Transplantation and Cellular Therapy39 citationsDOIOpen Access PDF

Topics & Concepts

MedicineChemotherapyCytokine release syndromeInternal medicineBlinatumomabOncologyHazard ratioLeukemiaSurgeryChimeric antigen receptorCancerImmunotherapyConfidence intervalLymphoblastic LeukemiaCAR-T cell therapy researchVirus-based gene therapy research
Impact of Bridging Chemotherapy on Clinical Outcomes of CD19-Specific CAR T Cell Therapy in Children/Young Adults with Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia | Litcius